Cargando…
Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic
Post-COVID-19 infection symptoms such as mental fog, tachycardia, and extreme fatigue are just a few of the symptoms wreaking havoc on patients’ lives. Patients with long-term symptoms following COVID-19 are being called long haulers. To date, long haulers are receiving little to no guidance from ph...
Autores principales: | Mitrani, Maria Ines, Bellio, Michael A., Meglin, Allen, Khan, Aisha, Xu, Xiumin, Haskell, Gwendolyn, Arango, Alissa, Shapiro, George C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405236/ https://www.ncbi.nlm.nih.gov/pubmed/34485048 http://dx.doi.org/10.1016/j.rmcr.2021.101502 |
Ejemplares similares
-
Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection
por: Bellio, Michael A., et al.
Publicado: (2021) -
Administration of amniotic fluid derived extracellular vesicle is associated with decreased crp in COVID-19 patients
por: Mitrani, M., et al.
Publicado: (2021) -
Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients
por: Mitrani, Maria Ines, et al.
Publicado: (2021) -
Human amniotic fluid derived extracellular vesicles attenuate T cell immune response
por: del Rivero, Tania, et al.
Publicado: (2022) -
COVID-19 long haulers
por: Schmidt, Charles
Publicado: (2021)